Navigation Links
Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis

BOCA RATON, Fla.--(BUSINESS WIRE)--Mar 22, 2007 - Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has today announced that its drug discovery division, ReceptoPharm, has received notification of acceptance of its paper for publication in the Critical Reviews in Immunology special conference issue.

The article, entitled "Alpha-Cobratoxin as a possible therapy for Multiple Sclerosis; a review of the literature leading to its development for this application," discusses the background and reasoning behind ReceptoPharm's research on its treatment for Multiple Sclerosis (MS). The Company has completed Phase I studies and is preparing to begin its Phase II human clinical trials.

"We are honored to have our paper accepted for publication in such a well respected journal," commented Paul Reid, CEO of ReceptoPharm, Inc. "Alpha-Cobratoxin could play an important role in treating Multiple Sclerosis and we believe it is important to disseminate our research throughout the scientific community," he added.

Recently, ReceptoPharm announced it received a letter of intent to create a joint venture in China aimed at developing the Company's antiviral drug, RPI-MN, for the Chinese market. RPI-MN is ReceptoPharm's lead drug candidate being researched for the treatment of HIV/AIDS and other viral disorders.

About Critical Reviews in Immunology

The great advances in immunology in recent years make this field one of the most rapidly growing in biological sciences. Critical Reviews(TM) in Immunology presents a balanced overview of contemporary immunology and melds together molecular immunology and immunobiology. The Journal is published six times each year.

http://www.begellhouse.com/journals/2ff21abf44b19838.html

About Nutra Pharma Corp.

Nutra Pharma Corp. is a biopharmaceutical company specializing in the acquisition, l
'"/>




Page: 1 2 3

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:12/24/2014)... -- Echo Therapeutics, Inc. (NASDAQ: ECTE ... permeation, continuous glucose monitoring and associated technologies, today ... been appointed Chief Executive Officer effective December 22, ... of experience in the medical device, pharmaceutical and ... Vice President, Business Development, Otsuka Pharmaceuticals as well as ...
(Date:12/24/2014)...   Assurex Health, a personalized medicine company ... for behavioral health and chronic pain conditions, today ... equity financing from new and existing investors, according ... Chief Executive Officer. The financing will ... Health,s GeneSight ®  products.  GeneSight,s patented ...
(Date:12/24/2014)... RALEIGH, N.C. , Dec. 23, 2014 ... plc (NASDAQ: ENDP ) (TSX: ENL), and ... announced today that they have submitted a New Drug ... U.S. Food and Drug Administration (FDA).  Buprenorphine HCl Buccal ... severe enough to require daily, around-the-clock, long-term opioid treatment ...
Breaking Medicine Technology:Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5
(Date:12/25/2014)... (PRWEB) December 25, 2014 Residents ... Retirement Community, recently showed their generous spirit by ... the Catawba County Parenting Network- Grandparents Raising Grandchildren ... children gathered around the largest Christmas tree on ... presents purchased by residents of the Abernethy Village ...
(Date:12/24/2014)... Over 700 toys, that’s what AlignLife clinics ... smiling little faces this holiday that might not have ... donations was given to the various charities as well ... through the year. Some of the charities chosen for ... Shrine's Children's Hospitals, Toys for Tots and Crisis Nurseries, ...
(Date:12/24/2014)... New York (PRWEB) December 24, 2014 ... mount in a mass tort litigation currently underway in ... reports. As of December 24, 2014, court documents ... proceeding on behalf of individuals who developed gynecomastia (male ... use. Data from the Court indicates that this represents ...
(Date:12/24/2014)... Today, UWDress.com, the famous women’s dress supplier, ... and launched a site-wide wedding gown promotion. , ... in a more unexpected way, the collection should be a ... the global market, and they are available with custom service. ... at discounted prices, up to 75% off; most of them ...
(Date:12/24/2014)... BambooIndustry.com a famous bamboo flooring company offering bamboo ... announces its multiple layer bamboo panel board collection ... products. , Bamboo panel is the product made from ... panel board features high quality selective bamboo and eco-friendly ... bamboo panel consists of multiple layers of bamboo. , ...
Breaking Medicine News(10 mins):Health News:Retirement Community Residents Make Impact During Holiday Season 2Health News:AlignLife Donates Over 700 Toys This Year 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Buy Cheap Long Sleeve Wedding Gowns At UWDress.com 2Health News:Bamboo Flooring Company Bambooindustry.com Introduces Its Multiple Layer Bamboo Panel Board Collection 2
... ... 300,000 reported cases annually, sudden cardiac death (SCD) is the leading ... in previously asymptomatic individuals, SCD generally results in death within six minutes in ... only five percent of SCD victims survive. Contrary to common perception, SCD ...
... , SIOUX FALLS, S.D., Sept. 15 ... of media and connectivity solutions to hospitality and healthcare businesses, will ... the Omni Hotel in New York City on Thursday, September 17, ... strategy and its progress on its initiatives to proactively manage its ...
... MINNEAPOLIS, Sept. 15 Breast cancer is one ... times more likely to have,stage IV breast cancer at the ... some of the reasons why breast cancer is so,prevalent among ... to educate and reinforce the importance of early detection and,diagnosis ...
... One in eight women will be diagnosed with breast cancer ... be personally impacted by the disease*. Since there are no cures ... Dr. Kristi Funk are joining forces this September and October to ... risk, early detection and meaningful ways to support the cause. Founder ...
... Conn., Sept. 15 The Connecticut Department of Transportation would like ... celebrate International Walk to School Day on October 7, 2009 with ... contest. Students are challenged to walk or bike to and from ... who can be the first to walk or bike the distance ...
... , CHICAGO, Sept. 15 Advanced Life Sciences ... United States Food and Drug Administration (FDA) has granted Orphan ... antibiotic, for the prophylactic treatment of plague and tularemia. ... Disease Control as Category A Bioterrorism Agents, which is the ...
Cached Medicine News:Health News:Filmmaker John Hughes' Recent Untimely Death is a Call for Better Understanding ,of Sudden Cardiac Death, the Leading Cause of Natural Death in the U.S. 2Health News:Filmmaker John Hughes' Recent Untimely Death is a Call for Better Understanding ,of Sudden Cardiac Death, the Leading Cause of Natural Death in the U.S. 3Health News:Filmmaker John Hughes' Recent Untimely Death is a Call for Better Understanding ,of Sudden Cardiac Death, the Leading Cause of Natural Death in the U.S. 4Health News:Filmmaker John Hughes' Recent Untimely Death is a Call for Better Understanding ,of Sudden Cardiac Death, the Leading Cause of Natural Death in the U.S. 5Health News:Filmmaker John Hughes' Recent Untimely Death is a Call for Better Understanding ,of Sudden Cardiac Death, the Leading Cause of Natural Death in the U.S. 6Health News:LodgeNet Interactive to Present at the CL King Best Ideas Conference 2Health News:LodgeNet Interactive to Present at the CL King Best Ideas Conference 3Health News:LodgeNet Interactive to Present at the CL King Best Ideas Conference 4Health News:LodgeNet Interactive to Present at the CL King Best Ideas Conference 5Health News:Adamari Lopez & Yoplait(R) Committed to Continue Raising Awareness for Breast Cancer Risk Reduction Among the Hispanic Community 2Health News:Adamari Lopez & Yoplait(R) Committed to Continue Raising Awareness for Breast Cancer Risk Reduction Among the Hispanic Community 3Health News:Video: Yoplait(R) and Celebrity Breast Cancer Surgeon Dr. Kristi Funk Emphasize Importance of Early Detection and Risk Reduction 2Health News:Video: Yoplait(R) and Celebrity Breast Cancer Surgeon Dr. Kristi Funk Emphasize Importance of Early Detection and Risk Reduction 3Health News:Safe Routes to School Challenges Connecticut Students to Walk It and Bike It to School 2Health News:Advanced Life Sciences Announces Restanza(TM) Granted FDA Orphan Drug Designation for Plague and Tularemia 2Health News:Advanced Life Sciences Announces Restanza(TM) Granted FDA Orphan Drug Designation for Plague and Tularemia 3
The Atakr II RF Generator provides high power output with the integral safety of closed-loop temperature control using the embedded thermocouples in Medtronic RF ablation catheters....
... The R-F10 simplifies the standard ... degree - all operations in ... press of the Start button, ... entire series of steps for ...
... EP-X Single Plane Imaging System is the ... efficiency for the electrophysiology specialist. The EP-X ... a totally integrated and dedicated EP lab ... minimal space requirements and Pulsed Progressive Fluoroscopy ...
... Bi-Plane Electrophysiology imaging have become more acute. ... and reduce radiation exposure to both patient ... between Single and Bi-Plane systems. In ... leadership position in price/value relationship, four bi-plane ...
Medicine Products: